Artemisia extracts differ from artemisinin effects on human hepatic CYP450s 2B6 and 3A4 in vitro
- 1 November 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 298, 115587
- https://doi.org/10.1016/j.jep.2022.115587
Abstract
No abstract availableKeywords
Funding Information
- American Association of University Women (NIH-2R15AT008277-02)
- NCCIH
This publication has 37 references indexed in Scilit:
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevanceFrontiers in Genetics, 2013
- Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countriesMalaria Journal, 2011
- The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao)Molecules, 2010
- Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseasesPhytochemistry Reviews, 2010
- The monoterpenoids citral and geraniol are moderate inhibitors of CYP2B6 hydroxylase activityChemico-Biological Interactions, 2008
- Reflections on the ‘discovery’ of the antimalarial qinghaoBritish Journal of Clinical Pharmacology, 2006
- EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLSDrug Metabolism and Disposition, 2005
- Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisininBritish Journal of Clinical Pharmacology, 1999
- CYTOCHROME P-450 3A4: Regulation and Role in Drug MetabolismAnnual Review of Pharmacology and Toxicology, 1999
- Metabolism of antimalarial sesquiterpene lactonesPharmacology & Therapeutics, 1990